findmyKOL

Apurva Modi, MD

Basic profile

Baylor Scott & White All Saints Medical Center

ORCIDNPI
RegionFort Worth, TX · South CentralSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Apurva Modi is a Gastroenterology physician affiliated with Baylor Scott & White All Saints Medical Center. OpenAlex indexes 36 publications with 2,548 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,548citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1250 8th Ave
Suite # 515
Fort Worth, TX 761044124

Telephone

817-922-9968

Registry record last updated 29 Jul 2015.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    44.7%
    Bile Acid12.4%
    Ursodiol100%
    Part D35 patients
    Rifamycin Antibacterial11.9%
    Xifaxan100%
    Part D23 patients

    + 7 more classes in this area

  • Cancer & immunology

    22.2%
    Calcineurin inhibitor13.6%
    Tacrolimus93%Cyclosporine Modified7%
    Part D<11 patients
    Purine Antimetabolite6.2%
    Azathioprine100%
    Part D15 patients

    + 1 more class in this area

  • Cardiovascular

    21.9%
    Aldosterone antagonist (MRA)10%
    Spironolactone100%
    Part D37 patients
    Loop diuretic9%
    Furosemide100%
    Part D36 patients

    + 1 more class in this area

Where care is delivered (Part B)38% facility · 62% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”